Eptinezumab Maintains Reductions in the Impact of Migraine

• Date :
• 1    
  0

Highlights From the 2019 American Headache Society Annual Scientific Meeting

• Date :
• 0    
  0

Interpreting Eptinezumab's Impact on HIT-6 Score

• Date :
• 0    
  0

A Combination Approach With nVNS in Migraine

• Date :
• 0    
  0

Noninvasive Vagus Nerve Stimulation's Novel Mechanism in Migraine

• Date :
• 0    
  0

Nerivio Migra Reduces Excess Medication Use In Migraine

• Date :
• 0    
  0

Introducing Nerivio Migra in Migraine Care

• Date :
• 0    
  0

Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

• Date :
• 0    
  0

Overcoming Barriers and Closing Gaps in Migraine

• Date :
• 0    
  0

Long-Term Safety in Preventive Migraine Therapies

• Date :
• 0    
  0

Using nVNS in Various Migraine Populations

• Date :
• 0    
  0

Lowering the Opioid Use Rates in Migraine

• Date :
• 0    
  0

Patient Referrals from Primary Care for Migraine

• Date :
• 0    
  0

Telemedicine for Headache Disorders

• Date :
• 0    
  0

Where Are Patients With Migraine Seeking Care?

• Date :
• 0    
  0

Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine

• Date :
• 0    
  0

Advantages of Eptinezumab and CGRP Inhibitors

• Date :
• 0    
  0

The Potential of the Gepant Class in Acute Migraine

• Date :
• 0    
  0

Coordinating Care in Telemedicine

• Date :
• 0    
  0

3rd International Conference on Neuroscience and Mental Health

• Date :
• 3715    
  0

The 93th American Association of Neurological Surgeons annual scientific meeting - AANS 2025

• Date :
• 2811    
  0

Congrès National 2024 des unités de soins, d’évaluation et de prise en charge Alzheimer

• Date :
• 3039    
  0

AES 2024 Annual Meeting

• Date :
• 2553    
  0

Journée du Président de la société française 2024

• Date :
• 9003    
  0